Research map: CAR T cells against the B cell receptor to precisely eliminate pathogenic B cells

Back to the article

Papers in this map

  1. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus · Andréas Mackensen · 2022 · 1101 citations · Cited by this paper
  2. CAR design equips diverse immune cells with unique antigen-specific activation identities · Ayano Sugiyama-Finnis · 2026 · Related
  3. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease · Christoph T. Ellebrecht · 2016 · 741 citations · Cited by this paper
  4. Rethinking lymphodepleting preconditioning in adoptive T cell therapy for durable tumor control · 2026 · Related
  5. Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma · Maurizio Bendandi · 1999 · 599 citations · Cited by this paper
  6. Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy · 2026 · Related
  7. Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma · Kitsada Wudhikarn · 2020 · 271 citations · Cited by this paper
  8. AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer · 2026 · Related
  9. Anti-Idiotype Antibodies Can Induce Long-Term Complete Remissions in Non-Hodgkin’s Lymphoma Without Eradicating the Malignant Clone · Thomas A. Davis · 1998 · 171 citations · Cited by this paper
  10. CART-immune-related adverse events after BCMA CAR-T therapy · 2026 · Related
  11. Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after ≥2 prior therapies · Laurie Helen Sehn · 2024 · 87 citations · Cited by this paper
  12. Unmasking Wnt-driven HCC: Inhibiting SMYD2 to overcome immune resistance · 2026 · Related
  13. CAR T cells Targeting Human Immunoglobulin Light Chains Eradicate Mature B-cell Malignancies While Sparing a Subset of Normal B Cells · Raghuveer Ranganathan · 2021 · 24 citations · Cited by this paper
  14. Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis · 2026 · Related
  15. Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia · Florian Märkl · 2024 · 15 citations · Cited by this paper
  16. Synergistic Cell-Cycle Repression by HDAC/EZH2 Co-Targeting in H3K27-Altered Diffuse Midline Glioma · 2026 · Related
  17. Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells · Ivan Cohen · 2026 · 12 citations · Cited by this paper
  18. Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity · 2026 · Related
  19. Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia · Elise A. Chong · 2024 · 7 citations · Cited by this paper
  20. Optimizing CAR T cell therapy in pancreatic cancer through clinically actionable combinations · 2026 · Related

Source: OpenAlex (CC0)